Cervical cancer develops in the lower part of the uterus and is usually caused by persistent HPV infection. It can often be prevented and detected early with regular screening and HPV vaccination. Modern treatments are effective and tailored to each patient
Who is at risk? Cervical cancer develops in women infected with high-risk HPV types. Risk may be higher in smokers, people with weakened immunity, or those who do not have regular screening. It usually occurs between ages 30–50, but can happen at any age
Detection and Diagnosis: Early cases are often found through routine Pap and HPV tests before symptoms appear. Later symptoms may include abnormal bleeding, unusual discharge, or pelvic pain Diagnosis is confirmed by biopsy, and imaging such as MRI or PET-CT may be used to determine the cancer stage
Treatment is stage-and patient-dependent:
Early stage: When the cancer is limited to the cervix
Locally advanced: spread to nearby tissues
Advanced / Stage IV: spread to distant organs
Treatment is given in personalized protocols based on stage and patient factors
Selected women with early-stage disease may preserve fertility. Options include conization for very small tumors or radical trachelectomy, which removes the cervix but keeps the uterus. Careful selection is required based on tumor size and spread, and lymph node evaluation is needed. Pregnancy is possible afterward but considered higher risk, requiring close monitoring.
We are here to guide and support you throughout diagnosis, treatment, and recovery. Please make an appointment via email at: [email protected]
Ext. 6